PE/VC  TPG

http://www.tpg.com





     Office Locations:

345 California Street, Suite 3300
San Francisco, CA 94104
Phone: 415-743-1500
Fax: 415-743-1501

Get all office locations for this firm with a National Database subscription or New York Database subscription.
 

Stages:

  • Early
  • Expansion
  • Late
  • Middle Market


 

Industries:

  • Business Services
  • Communications & Networking
  • Consumer Products & Services
  • Energy & Clean Tech
  • Financial Services
  • Information Technology
  • Life Sciences & Healthcare
  • Manufacturing & Industrial
  • Media & Digital Media
  • Retail & Restaurant
  • Software & Internet
  • Sports & Entertainment
  • Storage & Hardware
  • Transportation & Distribution

  •  

    Description:

    Founded 1992, TPG (formerly known as Texas Pacific Group) is a leading global private investment firm with over $96 billion of capital under management. TPG Capital is TPG's principal investment platform in the U.S., Europe, Asia, Australia and Latin America, and generally focuses on established businesses that require equity capital between $10 million and $1 billion. Investments in companies through acquisitions and restructurings span a broad range of industries including financial services, travel and entertainment, technology, retail, consumer products, healthcare, and media and communications. TPG Capital has had lead responsibility for more than 140 transactions, investing approximately $31.1 billion of equity capital across a number of economic and credit cycles. Among many different investment initiatives, TPG Growth is TPG's platform for smaller buyouts and growth equity investments globally. TPG Growth invests in a broad range of industries including consumer, retail, technology, internet, healthcare, energy, clean tech and renewables, transportation, industrials, and business services. TPG Growth utilizes a broad range of investment structures including leverage buyouts, growth equity, and private investment in public equities (PIPE's), and leverages the broader platform of TPG Capital. TPG Biotech is TPG's life science venture capital platform (see profile). TPG Opportunities Partners is TPG's platform for pursuing actively managed credit-related investment opportunities. Through this platform, TPG seeks to purchase or originate special situations/distressed investments across the credit cycle by targeting deep value opportunities that are difficult to source, analyze, or execute. TPG Specialty Lending is a specialty finance investment company focused on middle market lending and is managed through the TPG Opportunities Partners platform. The firm maintains 12 offices around the world.


     

    Funds:


      Fund Name


      Amount


      Date

    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription or New York Database subscription.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or New York Database subscription.
    Alastair Bushby VP
    Antonio Capo Operations Partner
    Beth Gibbs Field Operations Advisor
    Bill McGlashan Managing Director, Founder
    Charles Buaron VP

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      03/06/2024


      Sionna Therapeutics


      MA


      $182,000,000


      Series C


      12/20/2023


      Sudo Biosciences


      CA


      $116,000,000


      Series B


      08/11/2023


      Persefoni


      AZ


      $50,000,000


      Series C-1


      04/26/2023


      Ohmium


      NV


      $250,000,000


      Series C


     

    Portfolio companies include:


      Age of Learning
        web link


      Airbnb


      Anastasia Beverly Hills
        web link


      Anuvia Plant Nutrients
        web link


      Beautycounter
        web link


      C3 IoT
        web link


      Calm
        web link


      Caris Life Sciences


      Course Hero
        web link


      EverFi
        web link


      Form Energy
        web link


      Inocucor
        web link


      Kajabi
        web link


      Mercatus
        web link


      Monogram Health
        web link


      Ohmium
        web link


      PatientSafe
        web link


      Persefoni
        web link


      Precision Medicine Group
        web link


      project44
        web link


      Salsify
        web link


      Sionna Therapeutics
        web link


      STX Entertainment
        web link


      Sudo Biosciences
        web link


      Thatgamecompany
        web link


      Toast


      ViaCyte


      Zenoti
        web link


     

    Recent News: